ArticleStatistics in medicine2026
Integrating Omics and Pathological Imaging Data for Cancer Prognosis via a Deep Neural Network-Based Cox Model.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Modeling prognosis has unique significance in cancer research. For this purpose, omics data have been routinely used. In a series of recent studies, pathological imaging data derived from biopsy have also been shown as informative. Motivated by the complementary information contained in omics and pathological imaging data, we examine integrating them under a Cox modeling framework. The two types of data have distinct properties: for omics variables, which are more actionable and demand stronger interpretability, we model their effects in a parametric way; whereas for pathological imaging features, which are not actionable and do not have lucid interpretations, we model their effects in a nonparametric way for better flexibility and prediction performance. Specifically, we adopt deep neural networks (DNNs) for nonparametric estimation, considering their advantages over regression models in accommodating nonlinearity and providing better prediction. As both omics and pathological imaging data are high-dimensional and are expected to contain noises, we propose applying penalization for selecting relevant variables and regulating estimation. Different from some existing studies, we pay unique attention to overlapping information contained in the two types of data. Numerical investigations are carefully carried out. In the analysis of TCGA data, sensible selection and superior prediction performance are observed, which demonstrates the practical utility of the proposed analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.